Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of 6PGD in human A38-5 cells assessed as increase in Ru-5-P level at 15.6 uM incubated for 72 hrs by mass spectrometry
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of 6PGD in human A38-5 cells assessed as fold increase in 6PG level at 15.6 uM incubated for 72 hrs by mass spectrometry
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of 6PGD in human A38-5 cells assessed as increase in Ru-5-P level at 250 uM incubated for 72 hrs by mass spectrometry
Inhibition of 6PGD in human A38-5 cells assessed as fold increase in 6PG level at 250 uM incubated for 72 hrs by mass spectrometry
Inhibition of 6PGD in human A38-5 cells assessed as increase in intracellular H3K9me3 expression level at 1 to 250 uM incubated for 72 hrs by western blot analysis
Inhibition of 6PGD in human A38-5 cells assessed as fold increase in intracellular H3K9me3 level at 15.6 uM incubated for 45 mins by HTRF assay
Inhibition of 6PGD in human A38-5 cells assessed as increase in intracellular H3K9me3 level at 1 uM incubated for 45 mins by HTRF assay
Inhibition of 6PGD in human A38-5 cells assessed as increase in intracellular H3K9me3 level upto 250 uM incubated for 45 mins by HTRF assay
Inhibition of 6PGD in human A38-5 cells assessed as fold increase in intracellular H3K9me3 level at 250 uM incubated for 45 mins by HTRF assay
Inhibition of 6PGD in human A38-5 cells assessed as increase in intracellular H3K9me3 level at 0.1 to 1000 uM incubated for 45 mins by HTRF assay
Assay data:3 Active, 10 Tested
In Vitro Assay from Article 10.3109/14756360903257900: "Effects of some drugs on human erythrocyte 6-phosphogluconate dehydrogenase: an in vitro study."
Assay data:1 Active, 7 Tested
Enzyme Assay from Article 10.1080/14756360701546413: "Investigation of the effects of some sulfonamide derivatives on the activities of glucose-6-phosphate dehydrogenase, 6-phospho gluconate dehydrogenase and glutathione reductase from human erythrocytes."
Assay data:2 Active, 5 Tested
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
Genome-wide siRNA screen of genes regulating the Lipopolysaccharide-induced TNF-alpha response in human macrophages_Primary screen TNF readout
Assay data:2853 Active, 18113 Tested
SummaryRelated BioAssays by Same Project
A screen to identify synthetic lethal interactions with E-cadherin in an MCF10A isogenic cell line
Assay data:2442 Active, 18052 Tested
SummaryPubMed Citation
A screen to identify genes that regulate lymphatic endothelial cell migration - Primary Screen
Assay data:1034 Active, 18120 Tested
SummaryRelated BioAssays by Depositor
Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening
Assay data:15 Active, 2000 Tested
Identification of proteins required for the processing of the EWS-FLI1 nascent transcript
Assay data:59220 Tested
InfectX: Pathogen infection siRNA screens
Assay data:115372 Tested
A whole genome RNAi screen highlights components of the ER/Golgi as a prominent source of resistance to immunotoxin-mediated cytotoxicity
Assay data:555 Active, 64752 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on